期刊文献+

青年水痘31例发病2周内血常规分析

Analysis of routine blood within 2 weeks from onset on 31 cases of young patients
下载PDF
导出
摘要 目的探讨青年水痘患者发病2周内血常规的变化规律,为临床诊治提供依据。方法选取2012年2月—2015年11月我校青年水痘患者31例进行回顾性研究,分为2组,比较血常规各指标的差异。结果 4 d内,白细胞计数(WBC)、淋巴细胞计数(L)、淋巴细胞百分率水平较低,单核细胞百分率、血色素水平较高,与5 d^7 d时、1周~2周时比较有统计学差异(P<0.01或0.05)。4 d内,中性粒细胞(NE)百分率高于5 d^7 d时,中性粒细胞计数低于1周~2周时,单核细胞计数(M)高于1周~2周时,血小板计数(PLT)低于1周~2周时水平(P<0.01或0.05)。结论血常规检测对青年水痘患者的诊治有一定的参考价值。 Objective to study the change law of routine blood within 2 weeks from onset and to offer some reference value to diagnosis and treatment on young patients with Vericella. Methods Select 31 cases of young patients with varicella in our school from February 2012 to November 2015 and divided them into two groups according to their routine blood data. Their routine blood parameters on different times were analyzed retrospectively and compared matched-paired with him. Results The WBC.the lymphocyte count and the lymphocyte rate were all in low level,while the monocyte rate and the hemoglobin were in high level within 4 days.They were much lower/higher than that on 5~7 days and 1 ~2 weeks (P〈0.01 or 0.05).The neutrophile rate was higher within 4 days than that on 5~7 days (P〈0.05).The monocyte count was higher within 4 days than that on 1 ~2 weeks (P〈0.05).The neutrophile count within 4 days was slightly lower (P〈0.05)and the platelet count within 4 days was much lower (P〈0.01)than that on 1 ~2 week,s. Conclusion routine blood has a certain reference value to diagnosis and treatment of young patients with vericella.
作者 刘明芳
出处 《基层医学论坛》 2016年第28期3906-3908,共3页 The Medical Forum
关键词 青年水痘患者 血常规 变化规律 分析 Young patients with varicella Routine blood Changelaw Analysis
  • 相关文献

参考文献9

二级参考文献79

  • 1张群寿.泛昔洛韦治疗带状疱疹50例[J].华西药学杂志,2008,23(2). 被引量:4
  • 2Marin M, Curis D, Chaves SS, et al. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [J]. MMWR, 2007, 56 (RR-4): 1-40.
  • 3Galilk, Lee b, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination [J]. N Engl J Med, 2002, 347 (24): 1909-1915.
  • 4Asano Y. Varicella vaccine: the Japanese experience[J]. J Infect Dis, 1996, 174 (suppl 3): s310-313.
  • 5A rvin AM. V aricella vaccine: genesis, efficacy, and attenuation [J]. V iro logy, 2001,284(2) :153.
  • 6A rgaw T, Cohen J I, Klutch M , et al. N ucleo tide sequences that distinguish Oka vaccine from parental Oka and other varicella 2 zo ster virus iso lates[J ]. Infect Dis, 2000, 181(3) :1153.
  • 7Mustafa MB,Arduino PG,Porter SR.Varicella zoster virus:review of its management.J Oral Pathol Med,2009,38(9):673-688.
  • 8Iseli A,Aebi C,Banz K,et al.Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland.Hum Vaccine,2009,5(12):58-62.
  • 9Odom RB,James WD,Berger TG.Andrew's disease of the skin:clincical dermatology.9 th ed.Beijing:Science Press,2001:484.
  • 10Middleton DB,Zimmerman RK,Mitchell KB.Vaccine schedules and procedures,2007.J Fan Pract,2007,56(2 SupplVaccines):S47-S60,C4-C8.

共引文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部